The Patent Finder

Terms ending in 2036

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,959,091Methods for Engineering T Cells for Immunotherapy by Using RNA-Guided Cas Nuclease System
In force
 · Medium confidence
CellectisIn forceMedium confidence
US 10,752,684ROR1 (NTRKR1) Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,759,868Trophoblast Glycoprotein (5T4, TPBG) Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,692,169Cells for Immunotherapy Engineered for Targeting Antigen Present Both on Immune Cells and Pathological Cells
In force
 · Medium confidence
CellectisIn forceMedium confidence
US 10,294,304Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,837,024Modifying Messenger RNA Stability in Plant Transformations
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,072,644Inhibitory Chimeric Antigen Receptors
In force
 · High confidence
Allogene Therapeutics, Inc.In forceHigh confidence
US 11,312,782Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,472,613Method for Modulating Car-Induced Immune Cells Activity
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,774,451Methods for Improving Functionality in NK Cell by Gene Inactivation Using Specific Endonuclease
In force
 · High confidence
CellectisIn forceHigh confidence
4 more term ends in 2036 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
10 of these are in force and held by Cellectis.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited